-- 根據週三提交給澳洲證券交易所的文件，Mayne Pharma Group（ASX：MYX）公佈未經審計的第三財季營收為8,520萬澳元，較上年同期的8,430萬澳元成長1%。 該公司同時報告稱，息稅折舊攤銷前的基本虧損為140萬澳元，較去年同期的330萬澳元虧損有所改善。 Mayne Pharma表示，公司將繼續評估資本配置策略，包括潛在的場內股票回購。
Related Articles
Asia
CGN Power's Q1 Profit Drops 9% on Lower Revenue
CGN Power (HKG:1816, SHE:003816) posted a 9% drop in attributable profit in the first quarter to 2.74 billion yuan from 3.02 billion yuan, according to filings with the Hong Kong and Shanghai bourses late Tuesday.Earnings per share edged down to 0.052 yuan from 0.060 yuan.Revenue plunged 13% to 16.3 billion yuan from 18.8 billion yuan, the nuclear power operator said.
$HKG:1816$SHE:003816
Asia
Metal Powder Works' Metal Powder Machine Achieves Annual Capacity of 100 Metric Tonnes; Shares Up 10%
Metal Powder Works' (ASX:MPW) NextGen machine achieved sustained annual production capacity of 100 metric tonnes, with an in-specification saleable yield surpassing 95%, according to a Wednesday filing with the Australian bourse.NextGen is designed for industrial-scale manufacturing of non-thermal, solid-state metal powders.The company plans to achieve 800 metric tonnes of installed capacity by 2028, which is estimated to require total capital outlay of about $2 million, the filing said.Shares rose 10% in morning trade on Wednesday.
$ASX:MPW
Asia
China Pacific Insurance's Q1 Profit Rises 4%; Revenue Down 1%
China Pacific Insurance (SHA:601601, HKG:2601) reported a 4% increase in net profit in the first quarter to 10 billion yuan from 9.6 billion yuan, according to filings with the Hong Kong and Shanghai bourses late Tuesday.Earnings per share fell to 0.94 yuan from 1 yuan.Revenue fell 1.2% to 92.5 billion yuan from 93.7 billion yuan, the insurer said.
$HKG:2601$SHA:601601